Synthesis and preclinical evaluation of [18F]AlF-NOTA-Asp2-PEG2-JR11 as a novel antagonist radioligand for PET imaging of somatostatin receptor
European Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.1007/s00259-024-06978-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Haoran Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, PET Center, Department of Nuclear Medicine, Nanfang Hospital, Southe…. Hauptthemen laut MEDLINE: Receptors, Somatostatin, Radiopharmaceuticals, Positron-Emission Tomography, Fluorine Radioisotopes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the National Key Research and Development Program, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, PET Center, Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
- School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
- GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, PET Center, Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. smu_lqx@163.com.
- GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, PET Center, Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. gtang0224@smu.edu.cn.
- School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China. gtang0224@smu.edu.cn.
ORCID-Profile: Ganghua Tang
Förderung
- National Natural Science Foundation of China
- the National Key Research and Development Program
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangzhou Science and Technology Plan
- Medical Products Administration of Guangdong Province
- Nanfang Hospital Talent Introduction Foundation of Southern Medical University
- President Foundation of Nanfang Hospital, Southern Medical University
- Guangzhou Key Research and Development Program on Agriculture and Social Development Science
Zitieren
APA
Liang, H., Chen, Z., Mo, C., Han, Y., Liu, Q., & Tang, G. (2025). Synthesis and preclinical evaluation of [18F]AlF-NOTA-Asp2-PEG2-JR11 as a novel antagonist radioligand for PET imaging of somatostatin receptor. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06978-2
Vancouver
Liang H, Chen Z, Mo C, Han Y, Liu Q, Tang G. Synthesis and preclinical evaluation of [18F]AlF-NOTA-Asp2-PEG2-JR11 as a novel antagonist radioligand for PET imaging of somatostatin receptor. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-024-06978-2
BibTeX
@article{Liang2025,
author = {Liang, Haoran and Chen, Zihao and Mo, Chunwei and Han, Yanjiang and Liu, Qingxing and Tang, Ganghua},
title = {Synthesis and preclinical evaluation of [18F]AlF-NOTA-Asp2-PEG2-JR11 as a novel antagonist radioligand for PET imaging of somatostatin receptor},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.1007/s00259-024-06978-2}
}
EUVIMED